Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients

Known disparities exist in the availability of pharmacogenomic information for minority populations, amplifying uncertainty around clinical utility for these groups. We conducted a multi-site inpatient pharmacogenomic implementation program among self-identified African-Americans (AA; n = 135) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Saulsberry, Loren, Danahey, Keith, Middlestadt, Merisa, O’Leary, Kevin J., Nutescu, Edith A., Chen, Thomas, Lee, James C., Ruhnke, Gregory W., George, David, House, Larry, van Wijk, Xander M. R., Yeo, Kiang-Teck J., Choksi, Anish, Hartman, Seth W., Knoebel, Randall W., Friedman, Paula N., Rasmussen, Luke V., Ratain, Mark J., Perera, Minoli A., Meltzer, David O., O’Donnell, Peter H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709436/
https://www.ncbi.nlm.nih.gov/pubmed/34945816
http://dx.doi.org/10.3390/jpm11121343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709436/
https://www.ncbi.nlm.nih.gov/pubmed/34945816
http://dx.doi.org/10.3390/jpm11121343

Ejemplares similares